Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Chris Hyungseop Han picked up the Award of Excellence at the 74th Annual International Magnesium Association (IMA) World Magnesium Conference held in Singapore last month.

Dr. Jan Guy (Immediate Past President, Executive Committee Member, Board of Directors of IMA) (left) Chris Hyungseop Han (right)

The IMA Awards of Excellence program, established in 1962, is an annual program open to all researchers and companies demonstrating outstanding examples of magnesium's use. Nominations are judged by a peer review panel of international experts and winners are recognised worldwide. 

Chris won the award of excellence for his research in the development of Biodegradable Magnesium Alloy for Orthopaedic Applications. 

Often a patient will need two parts of their bones screwed together, which then results in a second operation to have the screws removed. For the past 8 years, Chris has been a part of a research team that overcame these limitations and created a roadmap to the next generation of metallic biodegradable implant materials with completely biocompatible elements. A state of the art method to synchronise the corrosion potential was developed to control the corrosion rate. 

Working closely with major hospitals in Korea, the research team have performed several hundred cases of small bone fixation screws and the results have been promising. The BBC World News ‘Horizons’ programme recently featured the team’s research as a medical breakthrough.

Chris commented:

"I am deeply honoured to have received the award of excellence from IMA. I would like to thank my family, my supervisors (Dr James Edwards and Professor Sion Glyn-Jones), my mentors at Korea Institute of Science and Technology (Dr. Hyun-Kwang Seok and Dr. Yu-Chan Kim) and the U&I Corporation for their support over the years. I am hoping to collaborate with more professionals at Oxford to explore the new possibilities of these biodegradable metallic materials." 

 

clinical Trial Published Clinical Trial Published on PNAS

Similar stories

Immunology preprint reviews launched in Nature Reviews Immunology

Kennedy Main Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

A more tailored approach to treating psoriatic arthritis

Arthritis Botnar Funding Main

Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.

Motion-capture to help children walk: Oxford team support new gait laboratory in Ethiopia

Main Orthopaedics and trauma

The Research at Oxford on Analysis of Motion (ROAM) team at the University of Oxford have supported CURE Ethiopia Children’s Hospital to develop and open a brand new gait laboratory, the first of its kind in the country and the only other active gait lab on the African continent outside of South Africa.

Professor Eleanor Stride recognised in New Year’s Honours list 2021

Awards Main

Statutory Professor of Biomaterials is awarded Officer of the Order of the British Empire (OBE) for services to Engineering

Drug may boost vaccine responses in older adults

Kennedy Main

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research

Kennedy Main Research

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.